Pharmacology on the NREMT Paramedic Exam: Decisions, Not Memorized Protocols

Pharmacology has no domain of its own on the Paramedic exam

The National Registry Paramedic Certification Examination has six domains, and none of them is pharmacology. The test plan's statement of purpose expects a newly certified paramedic to apply knowledge of pharmacology, among other subjects, to choose interventions and destinations. In the content outline, medication decisions fit the "management" area of the four clinical domains and in Clinical Judgment, whose take-action step, in the National Registry's sample packet, asks which therapy or action to carry out. These are the Paramedic test plan's domains; the EMT exam uses a different blueprint.

So a medication item usually arrives inside a scenario, and the drug name is only part of it. Your protocols and medical director decide which drugs you carry and give.

Five questions behind most medication items

Practice naming which of the five a stem is asking before you look at the options. A wrong option can name the right drug at the wrong moment or by the wrong route.

Guideline-backed medication decisions, with setting and class

Doses on this page. Only two amounts appear here, each exactly as its guideline prints it: epinephrine 1 mg every 3 to 5 minutes for adults in cardiac arrest (AHA 2025, Part 9), and an aspirin loading dose of 162 to 325 mg in acute coronary syndrome (ACC/AHA 2025). Every other amount, including amiodarone, lidocaine, adenosine, atropine and all pediatric doses, comes from your protocols and medical director. In the National EMS Scope of Practice Model 2019, every paramedic medication route is limited to medical director approved medications.

A bradycardia decision, worked step by step

The patient is fictional. A 74-year-old woman feels faint and short of breath. Her heart rate is in the low 40s, her blood pressure is low, and she is pale and slow to answer.

1. Cause first. The 2025 guideline starts with evaluating and treating reversible causes (COR 1), so assess and treat the cause alongside urgent stabilization; do not delay indicated pacing or medication to finish the history.
2. Indication. She has acute bradycardia with hemodynamic compromise, the setting in which atropine is reasonable to raise the heart rate (2a).
3. Route and amount. These come from your protocol.
4. Reassessment. If her rate and pressure do not respond to atropine, the guideline lists rate-raising IV adrenergic agonists, such as epinephrine or dopamine, or transcutaneous pacing while she is prepared for transvenous pacing if needed.

Every step carries a condition that the guideline supplies, and three of them match the five questions above: indication, route and reassessment. Transcutaneous pacing is a paramedic-level skill in the Scope of Practice Model, so a Paramedic item can expect you to move to it when atropine fails. The ECG rhythm guide covers the tachycardia side of the same guideline.

The free mixed set's medication item is an anaphylaxis case that asks which drug comes first, an indication question. With the table in hand, test the anaphylaxis first-drug item in the free NREMT Paramedic set →.

How to study medications for a decision exam

• Make one card per decision, not per drug. Write the drug, the setting, the blocking condition, the route and the reassessment cue, plus the guideline and year. Epinephrine needs separate cards for cardiac arrest and for anaphylaxis, because the setting changes the route and the source.
• Learn amounts from your protocol. The exam's items are referenced to industry-standard source materials, according to the test plan, but your program and medical director decide what you give.
• Watch the guideline edition. Several arrest rows changed in 2025; the 2025 AHA changes guide lists them.

For the acute coronary syndrome rows in context, see the 12-lead ECG and STEMI guide. For the arrest rows in sequence, see the cardiac arrest guide, and for opioid overdose, anaphylaxis and heat stroke as full cases, the medical emergencies guide.